BiotechTube
Home/nVector/Dr. Ivette Sandoval
DI

Dr. Ivette Sandoval

Head of Vector Development

nVector

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Parkinson's DiseaseHuntington's DiseaseAlzheimer's DiseaseTraumatic Brain Injury

nVector Pipeline

DrugIndicationPhase
nAV-101Amyotrophic Lateral Sclerosis (ALS)Pre-clinical
nAV-102Huntington's Disease and Parkinson's DiseasePre-clinical
CGT-102/CGT-103 (with CavGene Inc.)Parkinson's Disease (dyskinesias)Pre-clinical

Leadership Team at nVector

DF
Dr. Fredric Manfredsson
Leader in gene therapy research (specific title not listed)
DR
Dr. Robert Bowser
Leader in ALS research, heads biomarker efforts
JA
Jiyan An
Lab Manager
View full nVector profile